Longevity Research · Lisbon 2025

The cell
remembers
its youth.

Kanathos investigates the molecular signals present at the origin of cellular life — applying controlled epigenetic reprogramming to restore biological function in aged tissues.

Partial epigenetic reprogramming model
Our Approach

Reprogramming the epigenetic clock

Every cell carries the complete memory of its youngest possible state. At the origin of every life cycle, a precise molecular reset occurs — erasing decades of accumulated biological noise.

Kanathos studies this reset mechanism. Our platform applies controlled, partial reprogramming signals derived from germline biology to restore youthful cellular function — without erasing cellular identity.

01
Epigenetic Restoration
Targeted reversal of age-associated methylation patterns using precision factor delivery, guided by epigenetic clock measurements.
02
Germline Signal Research
Investigation of the reprogramming factors naturally expressed during gametogenesis — the body's own blueprint for cellular renewal.
03
Partial Reprogramming
Transient exposure to pluripotency signals to restore youthful gene expression without compromising cell-type identity.
04
Biomarker Validation
Continuous measurement via multi-omic biological age clocks to validate rejuvenation depth and monitor safety in real time.
Platform Sciences

Where disciplines converge

Our interdisciplinary platform unites epigenetics, reproductive biology, computational science, and regenerative medicine — bound by one hypothesis: biological age is a writable parameter.

Epigenomics Germline Biology iPSC Technology Geroscience AI Protein Design Chemical Reprogramming Transcriptomics Regenerative Medicine
Epigenetics
DNA methylation patterns, histone modification, chromatin remodeling
Reproductive Biology
Gametogenesis, germline epigenetic reset mechanisms
Cellular Reprogramming
Partial iPSC protocol · Yamanaka factors · Epigenetic clock reversal
Computational Biology
AI protein design, multi-omic aging clock analysis
Regenerative Medicine
Tissue renewal, translational clinical pathways
Global Research Network

Three sites.
One mission.

🇵🇹
Lisbon
Portugal · Headquarters
Corporate HQ & Clinical Strategy
Incorporated under Portuguese law within the EU biotech regulatory framework. Houses executive leadership, investor relations, and translational medicine coordination.
🇬🇷
Athens
Greece · Research Core
Scientific Leadership & R&D
Primary research and development hub. Our core scientific team — specialists in epigenetics, molecular biology, and computational modeling — is based at our Athens facility.
🇸🇳
Dakar
Senegal · Field Research
Longitudinal Population Studies
Our West African research site enables access to genetically diverse longitudinal cohorts, accelerating biological age research across underrepresented populations and expanding the scope of our validation studies.
Backed By

Our investors

Lead Investor
Céu e Terra
Lisbon, Portugal
A Lisbon-based multi-sector investment and development group with deep roots in real estate, technology, and international ventures across Europe and the Middle East. Céu e Terra brings strategic capital and cross-border network access to the Kanathos platform.
Strategic Partner
Hellenic
Life Sciences
Athens, Greece
A Greek science-focused investment group committed to advancing biotechnology and longevity research from the European Mediterranean corridor. Provides scientific advisory, regulatory guidance, and access to the Hellenic research ecosystem.

The biology
of renewal

We are building the scientific and clinical foundation for a future in which biological age becomes a controllable parameter. If you share this conviction — as an investor, researcher, or partner — we would like to hear from you.